Plasmodium berghei Subunit Vaccine: Repeat Synthetic Peptide of Circumsporozoite Protein Comprising T- and B-Cell Epitopes Fails to Confer Immunity
- 1 February 1990
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 31 (2), 237-242
- https://doi.org/10.1111/j.1365-3083.1990.tb02764.x
Abstract
In the murine malaria model induced by Plasmodium berghei, we studied the immunogenicity of the repeat region ofthe circumsporozoite (CS) protein, which is the main target of the antibody response in infected animals. We immunized several strains with a synthetic peptide‐‐Y(DPPPPNPN)3‐‐corresponding to one of the two P. berghei repeat sequences in complete Freund's adjuvant. Only C57BL/6 immunc sera reacted with the synthetic peptide in ELISA and with the native CS protein on P. berghei sporozoites, as detected by immunofluorescence. From lymph node cells of immunized C57BL/6 we isolated two repeat‐specific T‐cell lines which proliferated in the presence of the synthetic peptide or the recombinant CS protein. We analysed the protective role of this repeat‐specific response by injecting infectious sporozoites into mice immunized with irradiated sporozoites or with the repeat peptide. The percentage of mice developing parasitaemia was 80‐90% in the peptide‐immunized group and only 10‐20% in the group immunized with irradiated sporozoites. Anti‐repeat antibody titres were comparable in the two groups. On the basis of these results, we can conclude that the T‐ and B‐cell response to the CS repeat obtained with this synthetic peptide immunization is not sufficient for a protective immunity.This publication has 19 references indexed in Scilit:
- Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium bergheiEuropean Journal of Immunology, 1988
- Variation among circumsporozoite protein genes from rodent malariasMolecular and Biochemical Parasitology, 1988
- γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoitesNature, 1987
- Synthetic peptide vaccine confers protection against murine malaria.The Journal of Experimental Medicine, 1987
- Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoitesNature, 1987
- SAFETY AND EFFICACY OF A RECOMBINANT DNA PLASMODIUM FALCIPARUM SPOROZOITE VACCINEThe Lancet, 1987
- Efficacy of Murine Malaria Sporozoite Vaccines: Implications for Human Vaccine DevelopmentScience, 1987
- Expression in yeast of a Plasmodium vivax antigen of potential use in a human malaria vaccine.The Journal of Experimental Medicine, 1987
- Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection.The Journal of Experimental Medicine, 1980
- Antibodies to Sporozoites: Their Frequent Occurrence in Individuals Living in an Area of Hyperendemic MalariaScience, 1979